Grazoprevir (MK-5172)+ Elbasvir (MK-8742) for the Treatment of Acute Hepatitis C Genotype 1/4. The Dutch Acute HCV in HIV Study (DAHHS-2)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms DAHHS-2
- 03 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 03 Feb 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Feb 2018.
- 03 Feb 2018 Status changed from recruiting to active, no longer recruiting.